Bristol-Myers Squibb
BMY
BMY
2,527 hedge funds and large institutions have $111B invested in Bristol-Myers Squibb in 2023 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 1,049 increasing their positions, 1,008 reducing their positions, and 136 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
9% less first-time investments, than exits
New positions opened: 124 | Existing positions closed: 136
2% less funds holding
Funds holding: 2,590 → 2,527 (-63)
9% less funds holding in top 10
Funds holding in top 10: 75 → 68 (-7)
Holders
2,527
Holding in Top 10
68
Calls
$1.6B
Puts
$1.03B
Top Buyers
| 1 | +$603M | |
| 2 | +$297M | |
| 3 | +$268M | |
| 4 |
BlackRock
New York
|
+$198M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$169M |
Top Sellers
| 1 | -$680M | |
| 2 | -$306M | |
| 3 | -$297M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$188M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$167M |